Defective LAT signalosome pathology in mice mimics human IgG4-related disease at single-cell level

被引:4
|
作者
Joachim, Anais [1 ]
Aussel, Rudy [1 ]
Gelard, Lena [1 ,2 ]
Zhang, Fanghui [1 ,3 ]
Mori, Daiki [1 ,2 ]
Gregoire, Claude [1 ]
Villazala Merino, Sergio [1 ]
Gaya, Mauro [1 ]
Liang, Yinming [3 ]
Malissen, Marie [1 ,2 ,4 ]
Malissen, Bernard [1 ,2 ,4 ]
机构
[1] Aix Marseille Univ, Ctr Immunol Marseille Luminy, CNRS, INSERM, Marseille, France
[2] Aix Marseille Univ, Ctr Immunophen, CNRS, INSERM, Marseille, France
[3] Xinxiang Med Univ, Sch Lab Med, Henan Key Lab Immunol & Targeted Therapy, Xinxiang, Peoples R China
[4] Xinxiang Med Univ, Sch Lab Med, Lab Immunophen, Xinxiang, Peoples R China
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2023年 / 220卷 / 11期
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; CYTOTOXIC T-LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDER; ZETA-CHAIN; RECEPTOR; ACTIVATION; EXPRESSION; MUTATION; DIFFERENTIATION; RLTPR;
D O I
10.1084/jem.20231028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice with a loss-of-function mutation in the LAT adaptor (Lat(Y136F)) develop an autoimmune and type 2 inflammatory disorder called defective LAT signalosome pathology (DLSP). We analyzed via single-cell omics the trajectory leading to Lat(Y136F) DLSP and the underlying CD4+ T cell diversification. T follicular helper cells, CD4+ cytotoxic T cells, activated B cells, and plasma cells were found in Lat(Y136F) spleen and lung. Such cell constellation entailed all the cell types causative of human IgG4-related disease (IgG4-RD), an autoimmune and inflammatory condition with Lat(Y136F) DLSP-like histopathological manifestations. Most previously described T cell-mediated autoimmune manifestations require persistent TCR input. In contrast, following their first engagement by self-antigens, the autoreactive TCR expressed by Lat(Y136F)CD4+ T cells hand over their central role in T cell activation to CD28 costimulatory molecules. As a result, all subsequent Lat(Y136F)DLSP manifestations, including the production of autoantibodies, solely rely on CD28 engagement. Our findings elucidate the etiology of the Lat(Y136F) DLSP and qualify it as a model of IgG4-RD.
引用
收藏
页数:30
相关论文
共 50 条
  • [31] Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease
    Choi, Su Jin
    Ahn, Soo Min
    Oh, Ji Seon
    Hong, Seokchan
    Lee, Chang-Keun
    Yoo, Bin
    Kim, Yong-Gil
    PLOS ONE, 2023, 18 (03):
  • [32] IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease
    Geyer, Julia T.
    Niesvizky, Ruben
    Jayabalan, David S.
    Mathew, Susan
    Subramaniyam, Shivakumar
    Geyer, Alexander I.
    Orazi, Attilio
    Ely, Scott A.
    MODERN PATHOLOGY, 2014, 27 (03) : 375 - 381
  • [33] Roles of IgG4 and IgG4/IgG ratio to IgG4-related disease in patients with elevated serum IgG4 level
    Wang, Hai
    Wang, Chunling
    Wan, Qin
    Li, Li
    CLINICAL RHEUMATOLOGY, 2023, 42 (03) : 793 - 800
  • [34] Roles of IgG4 and IgG4/IgG ratio to IgG4-related disease in patients with elevated serum IgG4 level
    Hai Wang
    Chunling Wang
    Qin Wan
    Li Li
    Clinical Rheumatology, 2023, 42 : 793 - 800
  • [35] IgG4-related disease in pediatric patients: a single-center experience
    Ümmüşen Kaya Akca
    Erdal Atalay
    Müşerref Kasap Cüceoğlu
    Seher Şener
    Zeynep Balık
    Özge Başaran
    Ezgi Deniz Batu
    Ömer Karadağ
    Seza Özen
    Yelda Bilginer
    Rheumatology International, 2022, 42 : 1177 - 1185
  • [36] IgG4-related disease in pediatric patients: a single-center experience
    Akca, Ummusen Kaya
    Atalay, Erdal
    Cuceoglu, Muserref Kasap
    Sener, Seher
    Balik, Zeynep
    Basaran, Ozge
    Batu, Ezgi Deniz
    Karadag, Omer
    Ozen, Seza
    Bilginer, Yelda
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (07) : 1177 - 1185
  • [37] CHARACTERISATION OF A GROUP OF PATIENTS WITH IGG4-RELATED DISEASE: SINGLE CENTRE EXPERIENCE
    Kozlova, A.
    Burlakov, V.
    Abramov, D.
    Laberko, A.
    Sagoyan, G.
    Shcherbina, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1651 - 1651
  • [38] IGG4-RELATED DISEASE MANAGED WITH MYCOPHENOLATE: A SINGLE-CENTRE EXPERIENCE
    Andres, M.
    Vela, P.
    Begazo, A.
    Pascual, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1004 - 1005
  • [39] RITUXIMAB TREATMENT OF IGG4-RELATED DISEASE: A SINGLE-CENTER EXPERIENCE
    Sokol, E.
    Vasilyev, V.
    Palshina, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 397 - 398
  • [40] Rituximab in IgG4-Related Disease: A Large Single-Center Experience
    Wallace, Zachary
    Carruthers, Mollie
    Stone, John H.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1224 - S1224